WHWK — Whitehawk Therapeutics Share News
0.000.00%
Last trade - 00:00- $183.00m
- -$6.98m
- $7.15m
Brief: Aadi Bioscience Enters Into Amendment With Fresenius Kabi
Brief: Aadi Bioscience Announces Financial Results For Third Quarter
Aadi Bioscience Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aadi Bioscience Announces Planned Leadership Transition
Aadi Bioscience Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: Aadi Bioscience Announces Improved Anti-Tumor Activity Of Kras Inhibitors With NAB-Sirolimus
Brief: Aadi Bioscience Inc Files Prospectus Relates To Offer, Resale From Time To Time Of Up To 5.8 Million Shares Of Common Stock By Selling Stockholders
Brief: Mirati Therapeutics And Aadi Bioscience Partner To Evaluate Combination Of Adagrasib With NAB-Sirolimus In Patients With Advanced Non-Small Cell Lung Cancer And Other Solid Tumors With A Kras Mutation
Brief: Aadi Bioscience Announces Improved Anti-Tumor Activity Of KRAS Inhibitors In Combination With NAB-Sirolimus
Brief: Aadi Bioscience Announces $72.5 Mln Private Placement Equity Financing
Aadi Bioscience Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aadi Bioscience Announces Financial Results For The Second Quarter Of 2022
Aadi Bioscience Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Aadi Bioscience Inc - On June 27, Co Got Written Notice From EOC Pharma Limited
Brief: Aadi Bioscience Announces Exploratory Biomarker Data From Patients In Its Ampect Trial And Expanded Access Program To Be Presented At 2022 Asco Annual Meeting
U.S. RESEARCH ROUNDUP-First Solar, Henry Schein, Petiq
Aadi Bioscience Inc reports results for the quarter ended in March - Earnings Summary
Brief: Aadi Bioscience Reports First Quarter 2022 Financial Results
Brief: Aadi Bioscience Reports First Quarter 2022 Financial Results And Provides A Corporate Update